How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market
- By Service Type: ECMO Equipment Management, ECMO Staffing and Training, ECMO Maintenance and Repair, ECMO Clinical Support Services, ECMO Program Development
- By End User: Hospitals, Specialty Clinics, Cardiovascular Centers, Neonatal Intensive Care Units (NICUs), Emergency Medical Services (EMS)
- By ECMO Modality: Veno-Arterial (VA) ECMO, Veno-Venous (VV) ECMO, Hybrid ECMO
- By Contract Model: Full-Service Outsourcing, Staff Augmentation, Consulting and Advisory Services, Managed Services
- By Patient Age Group: Neonatal ECMO, Pediatric ECMO, Adult ECMO
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - ECMO Equipment Management leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 13 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 13 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 13 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
End User 5
ECMO Modality 3
Contract Model 4
Patient Age Group 3
Companies profiled
Medtronic plc
Getinge AB
LivaNova PLC
Sorin Group (LivaNova)
Terumo Corporation
Maquet (Getinge Group)
Xenios AG (Fresenius Medical Care)
Hemovent GmbH
CardiacAssist Inc.
Abiomed Inc.
Nipro Corporation
Sorin Group
+1 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
13 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Getinge AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →LivaNova PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sorin Group (LivaNova)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Maquet (Getinge Group)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Xenios AG (Fresenius Medical Care)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Hemovent GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →CardiacAssist Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Abiomed Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Nipro Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Sorin Group
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Medos Medizintechnik AG (Fresenius Medical Care)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,417M by 2033 · 7.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- ECMO Equipment Management35.7
- ECMO Staffing and Training17.3
- ECMO Maintenance and Repair10.6
- ECMO Clinical Support Services17.9
- ECMO Program Development18.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$833.4M → $1,330M · 6.0%
Europe$580.9M → $901.4M · 5.6%
Asia Pacific$530.4M → $830.5M · 5.8%
Latin America$328.3M → $611.2M · 8.1%
Middle East and Africa$252.6M → $467.2M · 8.0%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.182026
7.202027
7.222028
7.222029
7.232030
7.242031
7.272032
7.282033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic plc10.7
- Getinge AB24.9
- LivaNova PLC10.4
- Sorin Group (LivaNova)10.8
- Terumo Corporation9.5
- Maquet (Getinge Group)5.6
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type22.7%
End User29.1%
ECMO Modality10.6%
Contract Model19.7%
Patient Age Group18.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.1
- Europe21.8
- Asia Pacific20.1
- Latin America14.8
- Middle East and Africa11.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic plc | 74 | 76 | 84 | 88 | 93 | 93 | 85 |
| Getinge AB | 85 | 73 | 87 | 71 | 93 | 78 | 81 |
| LivaNova PLC | 88 | 75 | 76 | 82 | 83 | 67 | 79 |
| Sorin Group (LivaNova) | 75 | 58 | 62 | 67 | 67 | 78 | 68 |
| Terumo Corporation | 58 | 61 | 71 | 72 | 52 | 59 | 62 |
| Maquet (Getinge Group) | 61 | 63 | 67 | 48 | 58 | 60 | 60 |
| Xenios AG (Fresenius Medical Care) | 64 | 49 | 45 | 54 | 63 | 44 | 53 |
| Hemovent GmbH | 47 | 58 | 60 | 39 | 45 | 50 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic plc
- Getinge AB
- LivaNova PLC
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic plc | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Getinge AB | ◐ | ✓ | ✓ | ◐ | ✓ | ◐ |
| LivaNova PLC | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Sorin Group (LivaNova) | ✓ | ◐ | − | ◐ | ◐ | ✓ |
| Terumo Corporation | ◐ | − | ◐ | ◐ | − | − |
| Maquet (Getinge Group) | ◐ | ◐ | ✓ | ◐ | − | − |
| Xenios AG (Fresenius Medical Care) | ◐ | ◐ | − | − | ◐ | − |
| Hemovent GmbH | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Medtronic plc85
2Getinge AB81
3LivaNova PLC79
4Sorin Group (LivaNova)68
5Terumo Corporation62
6Maquet (Getinge Group)60
7Xenios AG (Fresenius Medical Care)53
8Hemovent GmbH50
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Medtronic plcGetinge ABLivaNova PLC
Challenger1
Strong scale, closing on the leaders.
Sorin Group (LivaNova)
Contender2
Focused players with pockets of strength.
Terumo CorporationMaquet (Getinge Group)
Niche2
Specialists in a single segment or region.
Xenios AG (Fresenius Medical Care)Hemovent GmbH
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market — a $721M beachhead inside a $10.4B market.
Beachhead (SOM)$721Mobtainable near-term
Serviceable (SAM)$3.84Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
ECMO Equipment Management
Best fit — highest urgency & budget in Service Type.
Economic buyer76 fit
ECMO Staffing and Training
Strong fit — clear ROI and a fast path to value.
End user68 fit
ECMO Maintenance and Repair
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + ECMO Modality
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales40%
Partner / channel30%
Digital / self-serve21%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation14%
Closed-won5%
$17.9KCAC
$106KLTV
5.9:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market is a resilient opportunity — $3.64B by 2033, compounding at 5.1%.
TAM · 2025$2.43Btoday
TAM · 2033$3.64Bforecast
CAGR5.1%2027–2033
Cumulative$27.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.64BTotal addressable market
SAM$1.50BServiceable available market
SOM$306MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
13+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.64BLarge & growingTAM by 2033 at 5.1% CAGR
$1.50BServiceable nowreachable with today’s model
$306MBeachhead winobtainable near-term share
13+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$2.84BBear3.3% CAGR
$3.64BBase5.1% CAGR
$4.65BBull6.8% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market — a $5.20B market by 2033. Plan: grow share from 9.7% to 18.4%.
Market size · 2033$5.20Btotal addressable
Market CAGR3.6%2027–2033
Target share18.4%from 9.7% today
Revenue ambition$958Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.7% | 18.4% | On track |
| Revenue | $493M | $958M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 30.9% | 41.3% | At risk |
| Customer retention | 90.4% | 95.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $136M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market conversation — a $8.44B market you can size, segment and defend in minutes.
Market size · 2033$8.44Btotal opportunity
Growth10.9%CAGR to 2033
Addressable buyers905+accounts in scope
Typical ROI4.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.6×return on cost, year one
< 2 mopayback period
$61K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
13+players profiled in this market
Coverage includes
Medtronic plcGetinge ABLivaNova PLCSorin Group (LivaNova)Terumo CorporationMaquet (Getinge Group)Xenios AG (Fresenius Medical Care)Hemovent GmbH+5 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Extracorporeal Membrane Oxygenation (ECMO) Outsourcing Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Extracorporeal Membrane Oxygenation (ECMO) Equipment Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportExtracorporeal Magneto Transduction Therapy (EMTT) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportExtracorporeal Magnetic Levitation Artificial Heart Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportExtracorporeal Lithotripsy Equipment Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportExtracorporeal Life Support Technology Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportExtracorporeal Life Support System (ECLS) Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportExtracorporeal Life Support (ECLS) Product Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportExtracorporeal Life Support (ECLS) Devices Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportExtracorporeal Life-support (ECLS) Blood Pump Market
Market size, share, segmentation and regional forecast.
$543M market · 2025 base year
View reportExtracorporeal Life Support Devices Market
Market size, share, segmentation and regional forecast.
$999M market · 2025 base year
View reportExtracorporeal CO2 Removal Devices Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportExtracorporeal Circulation Supporting Intubation Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.